Diabetes mellitus (DM) is frequently associated with disturbances of the sexual function underlain by hypogonadism and neuropathy. These pathologicalconditions are successfully managed by androgens, alpha-lipoic acid, and phosphodiesterase type 5 inhibitors, besides compensation of carbohydratemetabolism. This paper reports results of evaluation of different methods for the treatment of erectile dysfunction in DM patients basedat Endocrinological Research Centre. Their combination ensured higher than 90% efficiency of therapy.

No abstract

This article is designed to discuss data on diabetic complications negatively affecting male fertility, such as retrograde ejaculation and secondary hypogonadismthat frequently occur in patients with diabetes mellitus. It has been shown that 5 - 10% of the DM1 patients present with retrogradeejaculation associated with long-term decompensation of carbohydrate metabolism. Over 40% of the patients with DM2 have decreased total andfree testosterone levels regardless of compensation of carbohydrate metabolism. These complications are managed using neurotropic therapy (retrogradeejaculation) and stimulatory hormonal therapy (secondary hypogonadism).